Amneal Pharmaceuticals
AMRX
AMRX
139 hedge funds and large institutions have $484M invested in Amneal Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 32 increasing their positions, 52 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.25% more ownership
Funds ownership: 66.78% → 69.03% (+2.3%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
38% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 52
Holders
139
Holding in Top 10
1
Calls
$1.74M
Puts
$1.03M
Top Buyers
| 1 | +$5.19M | |
| 2 | +$4.22M | |
| 3 | +$3.1M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$3.07M |
| 5 |
SGH
Sivik Global Healthcare
Greenwich,
Connecticut
|
+$2.86M |
Top Sellers
| 1 | -$6.43M | |
| 2 | -$2.92M | |
| 3 | -$1.67M | |
| 4 |
Bank of New York Mellon
New York
|
-$953K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$923K |